Literature DB >> 18791828

Rapid and significant induction of TRAIL-mediated type II cells in apoptosis of primary salivary epithelial cells in primary Sjögren's syndrome.

Hideki Nakamura1, Atsushi Kawakami, Naoki Iwamoto, Hiroaki Ida, Takehiko Koji, Katsumi Eguchi.   

Abstract

Expressions of the effector molecules of Fas-mediated apoptosis in primary cultured salivary gland epithelial cells (SGEC) of primary Sjögren's syndrome (pSS) remain to be clarified. We focused on Fas-mediated caspase cleavage compared to tumor necrosis factor-related apoptosis inducing ligand (TRAIL)-mediated apoptosis. Induction of apoptosis was performed by anti-Fas antibody coupled with PI3K inhibitor, or TRAIL. Activation of caspases, cytochrome C, and apoptotic protease activating factor-1 (Apaf-1) was determined by western blotting or immunofluorescence observed by confocal microscopy. Fas-mediated apoptosis and activation of caspase 3/8 were induced in the presence of LY294002. TRAIL-induced apoptosis in SGEC, which was stronger than that induced by anti-Fas antibody. TRAIL-induced caspase 9 cleavage accompanied by activation of cytochrome C and Apaf-1 were not mediated by anti-Fas antibody. Our results suggest that death receptor-dependent apoptosis in primary cultured SGEC is regulated by the engagement of type II cells in pSS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18791828     DOI: 10.1007/s10495-008-0261-2

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  10 in total

Review 1.  Sjögren syndrome: advances in the pathogenesis from animal models.

Authors:  J A Chiorini; D Cihakova; C E Ouellette; P Caturegli
Journal:  J Autoimmun       Date:  2009-10-02       Impact factor: 7.094

2.  TLR3-mediated apoptosis and activation of phosphorylated Akt in the salivary gland epithelial cells of primary Sjögren's syndrome patients.

Authors:  Hideki Nakamura; Yoshiro Horai; Takahisa Suzuki; Akitomo Okada; Kunihiro Ichinose; Satoshi Yamasaki; Takehiko Koji; Atsushi Kawakami
Journal:  Rheumatol Int       Date:  2012-03-29       Impact factor: 2.631

Review 3.  Mouse Models of Primary Sjogren's Syndrome.

Authors:  Young-Seok Park; Adrienne E Gauna; Seunghee Cha
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

4.  Defective Efferocytosis in a Murine Model of Sjögren's Syndrome Is Mediated by Dysfunctional Mer Tyrosine Kinase Receptor.

Authors:  Richard Witas; Astrid Rasmussen; Robert H Scofield; Lida Radfar; Donald U Stone; Kiely Grundahl; David Lewis; Kathy L Sivils; Christopher J Lessard; A Darise Farris; Cuong Q Nguyen
Journal:  Int J Mol Sci       Date:  2021-09-08       Impact factor: 6.208

5.  Bone marrow-derived macrophages from a murine model of Sjögren's syndrome demonstrate an aberrant, inflammatory response to apoptotic cells.

Authors:  Richard Witas; Yiran Shen; Cuong Q Nguyen
Journal:  Sci Rep       Date:  2022-05-21       Impact factor: 4.996

6.  TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3beta pathway and activation of caspases.

Authors:  Suk-Bin Seo; Jung-Gu Hur; Mi-Ju Kim; Jae-Won Lee; Hak-Bong Kim; Jae-Ho Bae; Dong-Wan Kim; Chi-Dug Kang; Sun-Hee Kim
Journal:  Mol Cancer       Date:  2010-07-28       Impact factor: 27.401

7.  Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines.

Authors:  Yuko Akazawa; Justin L Mott; Steven F Bronk; Nathan W Werneburg; Alisan Kahraman; Maria Eugenia Guicciardi; Xue Wei Meng; Shigeru Kohno; Vijay H Shah; Scott H Kaufmann; Mark A McNiven; Gregory J Gores
Journal:  Gastroenterology       Date:  2009-03-09       Impact factor: 22.682

8.  Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients.

Authors:  T Shimizu; H Nakamura; A Takatani; M Umeda; Y Horai; S Kurushima; T Michitsuji; Y Nakashima; A Kawakami
Journal:  Clin Exp Immunol       Date:  2018-11-28       Impact factor: 4.330

9.  HIF1α-mediated TRAIL Expression Regulates Lacrimal Gland Inflammation in Dry Eye Disease.

Authors:  Yong Woo Ji; Joon H Lee; Eun Young Choi; Hyun Goo Kang; Kyoung Yul Seo; Jong Suk Song; Hyeon Chang Kim; Hyung Keun Lee
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-01-23       Impact factor: 4.799

Review 10.  Modulation of Apoptosis by Cytotoxic Mediators and Cell-Survival Molecules in Sjögren's Syndrome.

Authors:  Hideki Nakamura; Yoshiro Horai; Toshimasa Shimizu; Atsushi Kawakami
Journal:  Int J Mol Sci       Date:  2018-08-11       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.